Website
Industry
Recent investment activity
Tags
KANDO id: 79860
Corporate information
Registration country
Company type
The corporate venture fund of the healthcare company RocheRelation
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 15 of 15Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Alnylam Pharmaceuticals Inc | N/A | |||||
Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | ||||
Conatus Pharmaceuticals Inc | Biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer. | N/A | ||||
CytomX Therapeutics | Developer of proteolytically-activated antibodies | Series B | ||||
Halozyme Therapeutics Inc (Halozyme Inc) | Biopharmaceutical company developing & commercializing products targeting the extracellular matrix. | N/A | ||||
Inimex Pharmaceuticals Inc | Series B | |||||
Intradigm Corp | N/A | |||||
IRX Therapeutics Inc | N/A | |||||
Nereus Pharmaceuticals Inc | Series E | |||||
Nereus Pharmaceuticals Inc | Series D | |||||
Addex Pharmaceuticals SA | Switzerland-based drug company focused on CNS disorders | N/A | ||||
Aileron Therapeutics Inc | Developing a breakthrough proprietary peptide technology platform | N/A | ||||
Horizon Discovery Ltd | Series C | |||||
Horizon Discovery Ltd | Series C | |||||
Opsona Therapeutics Ltd | Innate immune drug development company | Series C |